Dr Su Yin Lim

Macquarie University

Improving Current Melanoma Therapies

Esther’s research looks for ways to boost the human immune system to improve the effectiveness of current melanoma therapies.

Specifically, she investigates inhibitors for a protein pathway in the body known as MAPK, which plays a key role in the development of melanoma.

Work in this field has already improved survival rates of the 30-40% of Australian patients who have a form of the disease known as BRAF-mutant melanoma.

“Outcomes of this project will translate rapidly into clinical practice, and will hopefully help improve patients’ lives,” she says.